Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents

Documenti analoghi

• Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network
  di: Pauline Gandolfo, et al.
  Pubblicazione: (2024)
• Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France
  di: Marie‐Laure Laroche, et al.
  Pubblicazione: (2025)
• Use of Psychoactive Substances Before Incarceration Among Prison Inmates With Drug Abuse or Dependence: Data From the OPPIDUM Program
  di: Zeinab Abbas, et al.
  Pubblicazione: (2025)
• Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024
  di: Cécile Chevallier, et al.
  Pubblicazione: (2026)
• Characterization of the use of psychoactive substances in the university population
  di: Sandra Yaneth Quiroz Coral
  Pubblicazione: (2025)